Cannabis consumer packaged goods company Auxly Cannabis Group Inc. XLY CBWTF announced on Thursday its second quarter financial results for the three months ended June 30, 2024, revealing net revenues of CA$29.2 million ($21.3 million). That's an increase of 33% year-over-year and 16% compared to the previous quarter.
“After our best start to a year ever, we are thrilled to report our best Q2 in history, with exceptional financial performance setting a new Q2 record in revenue and all-time records in gross margin and adjusted EBITDA," said CEO Hugo Alves. "We are particularly proud of our significant gains in market share across all three of our core product categories, especially in the vapor segment where we are currently leading the growing all-in-one category, securing an impressive 32% share of market."
Read Also: Auxly Cannabis Achieves Record Q1: Adjusted EBITDA Soars 1,523%, Revenue Grows 5%, Strong 2024 Ahead
Q2 2024 Financial Highlights
- Gross profit was CA$15.9 million, resulting in a 55% gross margin compared to CA$6.1 million resulting in a 28% gross margin in the prior year's period.
- Selling, general and administrative expenses were CA$9.3 million in the second quarter of 2024, CA$0.5 million or 6% higher than the same period in 2023, primarily due to non-recurring restructuring-related costs during the period.
- Net income was CA$2 million as compared to a net loss of CA$12.9 million in the same period of 2023.
- Total other incomes and losses were a net loss of CA$0.1 million compared to a net loss of CA$1.6 million in the comparative period of 2023.
- Adjusted EBITDA came in positive at CA$5.2 million representing an improvement of CA$6.3 million over the same period of 2023, primarily due to improvements in gross profits and SG&A.
CBWTF Price Action
Auxly's shares traded 0.61% higher at $0.033 per share after the market close on Wednesday.
Read Next
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.